$3,350,000 of ELI LILLY AND COMPANY lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-India, and US-Brazil; US Tariffs Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care Intellectual property; 340B Program; Medicare & Medicaid prescription drug reimbursement, coverage and value; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality Pharmaceutical intellectual property issues Implementation and extension of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax; Pension and retirement benefit issues; round-tripping Hospital discounts; 340B program; Prescription drug value, access, quality and compliance with Drug Quality and Safety Act"
You can find more data on corporate lobbying on Quiver Quantitative.
LLY Congressional Stock Trading
Members of Congress have traded $LLY stock 19 times in the past 6 months. Of those trades, 4 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $LLY stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 13 times. They made 0 purchases and 13 sales worth up to $195,000 on 03/10, 02/19, 01/08, 12/18, 12/16, 12/13, 12/12, 12/11, 12/10, 12/09, 11/19, 11/14, 10/16.
- SENATOR RON WYDEN has traded it 2 times. They made 1 purchase worth up to $100,000 on 01/22 and 1 sale worth up to $100,000 on 02/10.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/21, 12/24 and 0 sales.
- REPRESENTATIVE GREG LANDSMAN sold up to $50,000 on 11/08.
- SENATOR SHELDON WHITEHOUSE purchased up to $50,000 on 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LLY Insider Trading Activity
LLY insiders have traded $LLY stock on the open market 56 times in the past 6 months. Of those trades, 0 have been purchases and 56 have been sales.
Here’s a breakdown of recent trading of $LLY stock by insiders over the last 6 months:
- ENDOWMENT INC LILLY has made 0 purchases and 51 sales selling 534,452 shares for an estimated $474,544,560.
- DANIEL SKOVRONSKY (EVP, CSO & Pres. LRL & LLY Imm) has made 0 purchases and 3 sales selling 5,000 shares for an estimated $4,316,064.
- DONALD A ZAKROWSKI (SVP, Finance, & CAO) has made 0 purchases and 2 sales selling 1,900 shares for an estimated $1,541,282.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LLY Hedge Fund Activity
We have seen 1,697 institutional investors add shares of LLY stock to their portfolio, and 1,604 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PROFICIO CAPITAL PARTNERS LLC added 5,197,038 shares (+100387.1%) to their portfolio in Q4 2024, for an estimated $4,012,113,336
- JPMORGAN CHASE & CO removed 3,259,646 shares (-17.9%) from their portfolio in Q4 2024, for an estimated $2,516,446,712
- FMR LLC removed 2,501,172 shares (-7.6%) from their portfolio in Q4 2024, for an estimated $1,930,904,784
- JENNISON ASSOCIATES LLC removed 2,151,072 shares (-31.0%) from their portfolio in Q4 2024, for an estimated $1,660,627,584
- WELLINGTON MANAGEMENT GROUP LLP added 2,012,129 shares (+19.0%) to their portfolio in Q4 2024, for an estimated $1,553,363,588
- CAPITAL INTERNATIONAL INVESTORS added 1,645,222 shares (+23.2%) to their portfolio in Q4 2024, for an estimated $1,270,111,384
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,614,296 shares (-99.1%) from their portfolio in Q4 2024, for an estimated $1,246,236,512
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LLY Analyst Ratings
Wall Street analysts have issued reports on $LLY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Leerink Partners issued a "Outperform" rating on 01/17/2025
- BMO Capital issued a "Outperform" rating on 11/18/2024
To track analyst ratings and price targets for LLY, check out Quiver Quantitative's $LLY forecast page.
LLY Price Targets
Multiple analysts have issued price targets for $LLY recently. We have seen 4 analysts offer price targets for $LLY in the last 6 months, with a median target of $990.0.
Here are some recent targets:
- An analyst from Morgan Stanley set a target price of $1146.0 on 03/06/2025
- Andrew Berens from Leerink Partners set a target price of $950.0 on 01/17/2025
- Kerry Holford from Berenberg Bank set a target price of $970.0 on 01/16/2025
- Evan David Seigerman from BMO Capital set a target price of $1010.0 on 10/31/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
